The ‘Price Savings’ of Drug Importation— Unboxing the Myth

Wayne Winegarden and Nouran Ghana’s editorial was published in Inside Sources on November 15, 2017. In it, they take a hard look at the supposed “price savings” of drug importation and find that the promises do not live up to what would happen. They believe that Americans deserve a better solution than plundering the drug supply of a neighboring country…

[...]

Proposed Bill Could Fuel the Opioid Epidemic

George M. Karavetsos’ editorial was published in The Hill on October 30, 2017. George M. Karavetsos is a partner with the global law firm DLA Piper. He formerly served as the director of the U.S. Food and Drug Administration’s Office of Criminal Investigations and chief of the Narcotics Section and the executive assistant U.S. attorney in the Southern District of Florida…

[...]

Former FBI Director Discusses the Dangers of Allowing Drug Importation in Radio Interview

Freeh warned that allowing drug importation from Canada was akin to allowing drugs to be imported from anywhere. Quality would be at risk, and the opioid crisis, an epidemic that killed over 33,000 Americans in 2015, would only get worse. He said that allowing drug importation, “…will not only fuel that, but it will also, in my opinion, encourage a lot of criminal groups and organizations that heretofore have not been involved in this trade, but will see huge opportunities to enter the market.”

[...]